A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer
Clinical trial NCT04300647 · COMPLETED
Trial details
- NCT number
- NCT04300647
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-12-08
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.